PeptideStack
5.2kquestions
20kanswers
220users

How would I detect fibrillation in a semaglutide vial without sending it to Medutest?

Asked 14 May 2026Modified 1 min agoViewed 4.8k times
19

For reference: fibrillation · semaglutide · Medutest.

I want a method I can write down and repeat, not a rule of thumb.

I would rather over-engineer this than discover a problem later, within reason.

So: what is the actual procedure, and which steps matter as opposed to being ritual?

vial-inspection
vial-inspection

What you can learn by looking: cake morphology, meniscus films, fibres versus stopper fragments versus true particulates, clarity after…

66 questions
peptide-stability
peptide-stability

The chemistry of peptide degradation: deamidation, oxidation, hydrolysis, aggregation and fibrillation, and how temperature, pH, ionic strength,…

832 questions
harm-reduction
harm-reduction

Reducing avoidable risk where a decision has already been made: independent verification before use, sterility practice, dose arithmetic checked…

445 questions
shareeditfollowflag
M1
askedmass_shift_1814k1814 May 2026
7Any reason this would differ for a longer peptide? – rae_oyelowo 6 months ago
add a comment

5 Answers

Accepted answer first, then by votes
38

Accepted answer

Specifically, two people working through the same arithmetic independently should get the same answer, and if they do not, someone has made a unit error.

Air bubbles at these volumes are a measurement problem rather than a safety one. A 2 mm bubble in a 0.3 mL syringe is roughly 4 µL, which at 10 units drawn is a four per cent error.

Reading a lyophilised cake

AppearanceInterpretationAction
Intact opaque puck, proud of baseCycle ran correctlyProceed
Slumped to one sideShipped before fully dry, or vibrationUsually usable; note it
Glassy translucent filmCollapse above glass transitionTest before use
Melt-back ring at stopperThermal excursion in transitTest before use
No visible cake at allVery low fill, or nothing thereWeigh it; query the supplier

In practice, dead space quantified: a fixed-needle insulin syringe holds roughly 3 to 5 µL in the hub and needle after the plunger bottoms out. A luer-lock syringe with a detachable needle holds 35 to 100 µL depending on the hub design. At 5 mg/mL that is 15 to 25 µg lost per draw on the insulin syringe and 175 to 500 µg on the luer-lock — which over ten draws is the difference between losing a rounding error and losing half a milligram.

The insulin-unit standard U-100 means 100 units per millilitre, so one unit is 0.01 mL — this is the conversion that trips up more people here than any other single piece of arithmetic.

Write the arithmetic on the vial label. It costs nothing and removes the step where you reconstruct it from memory.

shareimprove this answerflag
RP
answered · acceptedrhian_prydderch44k3831 May 2026
Do you have a reference for the last claim? Not disputing it, just want to read it. – p_mkhize 7 months ago
add a comment
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results
44

Write the units at every step, because units errors are the failure mode that catches everyone eventually.

On filtration: a 0.22 µm syringe filter will remove particulates and organisms, and it will also adsorb a fraction of your peptide onto the membrane — with a low-binding PVDF or PES membrane the loss is typically a few per cent.

Worth being precise here: number of stopper piercings matters less than the gauge doing the piercing. A 30G or 31G needle through a butyl stopper leaves a track that reseals; a 21G or 18G drawing needle punches a core and can drop it into the solution.

The content assay results from major testing services show that nominal vial claim and measured content differ by one to ten per cent, making content a driver of dose error.

Do the arithmetic twice, ideally with someone else doing it independently.

shareimprove this answerflag
IB
answeredines_brandt93k24818 Jul 2026
Related: the same reasoning applies to the counter-ion question. – Dr_Bram_Verhoeven 2 months ago
add a comment
30

The arithmetic only stops being confusing once you work it through once and see that it is straightforward.

Rotation of injection site is a tolerability measure, not a pharmacokinetic one, but if you are going to do it you might as well do it right.

Breaking it down further: if a 10 mg vial has 96.5 per cent content, you have 9.65 mg of peptide. Divide that by 2.00 mL and your concentration is 4.825 mg/mL, not 5.00 mg/mL, which is a 3.5 per cent systematic error in every dose calculation.

The Arrhenius relationship for drawing kinetics means that cold solution takes noticeably longer to draw than room-temperature solution.

If in doubt, use more diluent and accept the shorter usable window.

shareimprove this answerflag
EV
answeredesther_vandeVelde49k3824 Jun 2026
8Two of us worked through this independently and arrived here, so it is at least reproducible. – Dr_Priya_Raghunathan 6 months ago
7Worth adding that the method section is where the answer usually is. – Dr_Idris_Coulibaly 5 months ago
add a comment
18

This is one of those calculations where checking your work takes two minutes and prevents a very consequential error.

The concentration you actually work with is label claim times content fraction divided by actual diluent volume, which is usually not the same as the nominal concentration because content is usually not 100 per cent and you rarely measure the diluent volume to 0.1 mL precision.

Published data on syringe dead space quantifies low-dead-space designs as retaining under 2 µL against 35 µL or more for conventional detachable-needle syringes.

The caveat is that this assumes the vial contains what the label says, and if the content assay has not been done, the arithmetic is precise about an unknown quantity.

Write the arithmetic on the vial label. It costs nothing and removes the step where you reconstruct it from memory.

edited 8 Aug 2026 by hana_petrikova — updated for the 2026 guidance change

shareimprove this answerflag
HP
answeredhana_petrikova19k2823 Jul 2026
-1

The distinction that resolves most of these questions is understanding what concentration actually means and why it is not the same as label claim.

Do not use the same needle to pierce the stopper and to administer. The tip is blunted by the stopper, and the hub now contains a dose you are about to lose to dead space anyway.

The insulin-unit standard U-100 means 100 units per millilitre, so one unit is 0.01 mL — this is the conversion that trips up more people here than any other single piece of arithmetic.

I would flag the obvious failure mode: people get the concentration right, get the volume right, and then read the syringe against the wrong scale.

Do the arithmetic twice, ideally with someone else doing it independently.

edited 3 Jun 2026 by bea_forsberg — reworded for clarity after a comment

shareimprove this answerflag
BF
answeredbea_forsberg14k2822 May 2026
4The timing signature is the useful part. Everything else is confounded. – assay_blank 5 months ago
add a comment

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.